Literature DB >> 11530876

Phage displayed biomolecules as preventive and therapeutic agents.

K Manoutcharian1, G Gevorkian, A Cano, J C Almagro.   

Abstract

Phage display is a powerful technology for selecting and engineering peptides and proteins expressed on the surface of filamentous bacteriophage. The advantages of phage display technology over other research tools and its' great potential have been demonstrated by successful application of phage display in diverse fields of biomedical/clinical research. In this review we will describe some recent developments in phage display, including new expression vectors, display formats, bioselection strategies and applications in pharmaceutical biotechnology. We highlight some important applications of phage display to identify disease- and pathogen-specific biomolecules, making particular emphasis on development of phage display-derived preventive and therapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530876     DOI: 10.2174/1389201013378671

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  9 in total

Review 1.  Progress in phage display: evolution of the technique and its application.

Authors:  Tomaz Bratkovic
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

Review 2.  Phage display in molecular imaging and diagnosis of cancer.

Authors:  Susan L Deutscher
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.

Authors:  N E van Houten; M B Zwick; A Menendez; J K Scott
Journal:  Vaccine       Date:  2006-01-11       Impact factor: 3.641

Review 4.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates.

Authors:  Aneta Kłyż; Andrzej Piekarowicz
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  A general insert label for peptide display on chimeric filamentous bacteriophages.

Authors:  Gilad Kaplan; Jonathan M Gershoni
Journal:  Anal Biochem       Date:  2011-09-08       Impact factor: 3.365

7.  Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles.

Authors:  Paladd Asavarut; Sajee Waramit; Keittisak Suwan; Gert J K Marais; Aitthiphon Chongchai; Surachet Benjathummarak; Mariam Al-Bahrani; Paula Vila-Gomez; Matthew Williams; Prachya Kongtawelert; Teerapong Yata; Amin Hajitou
Journal:  EMBO Mol Med       Date:  2022-06-27       Impact factor: 14.260

8.  Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).

Authors:  Miles C Scotcher; Jeffery A McGarvey; Eric A Johnson; Larry H Stanker
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

9.  Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.

Authors:  Andrzej Piekarowicz; Aneta Kłyż; Michał Majchrzak; Daniel C Stein
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.